# Isabella

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/isabella

- Industry: Healthcare IT
- Latest round: Seed (Aug 5, 2026)
- Investors on record: 1

## About

Based in South Korea, Isabella is a digital healthcare company focused on women's health technologies. The company combines gynecological clinical expertise with sensing technologies to develop AI-driven healthcare solutions. Its flagship product, Lunéo, integrates low-temperature plasma and LED technologies with a companion application that analyzes user biometric data and provides personalized healthcare recommendations. Isabella collaborates with KAIST and KRISS on technology development and recently secured seed funding from CNTTech in August 2026. The company focuses on AI-based women's healthcare solutions, connected health devices, biometric data analytics, and personalized health management services. Its flagship product, Lunéo, is a home-care device integrated with the Coach Lunéo application, enabling users to monitor and manage women's health through data-driven insights. The company's revenue is generated through the sale of women's healthcare devices, digital health applications, and related personalized healthcare services. CNTTech invested in Isabella based on the growth potential of data-driven personalized healthcare and digital women's health solutions. The company plans to expand beyond connected healthcare devices into Software as a Medical Device (SaMD) and Digital Therapeutics (DTx), leveraging its sensing technology capabilities, clinical expertise, and partnerships with KAIST and KRISS.

## Funding rounds

- Seed, Aug 5, 2026 — CNT Tech

## Investors

- CNT Tech (https://capitalatlas.ai/funds/cnt-tech) — Seed